AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis

Stock Information for AI/ML Innovations Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AI/ML Innovations Inc

AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.